高尿酸血症和痛风病证结合诊疗指南

2021-01-20 中国医师协会中西医结合医师分会 世界中医药.2021.16(2):183-189.

高尿酸血症是指机体嘌呤代谢紊乱,尿酸分泌过多或肾脏排泄功能障碍,使尿酸在血液中积聚的状态。为规范临床一线医师高尿酸血症和痛风病证结合诊疗,中国医师协会中西医结合医师分会内分泌与代谢病学专业委员会组织制

中文标题:

高尿酸血症和痛风病证结合诊疗指南

英文标题:

世界中医药.2021.16(2):183-189.

发布日期:

2021-01-20

简要介绍:

高尿酸血症是指机体嘌呤代谢紊乱,尿酸分泌过多或肾脏排泄功能障碍,使尿酸在血液中积聚的状态。为规范临床一线医师高尿酸血症和痛风病证结合诊疗,中国医师协会中西医结合医师分会内分泌与代谢病学专业委员会组织制定本指南。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=高尿酸血症和痛风病证结合诊疗指南_2021_01_20_.pdf)] GetToolGuiderByIdResponse(projectId=1, id=ff7d91c002068e2b, title=高尿酸血症和痛风病证结合诊疗指南, enTitle=世界中医药.2021.16(2):183-189., guiderFrom=世界中医药.2021.16(2):183-189., authorId=0, author=, summary=高尿酸血症是指机体嘌呤代谢紊乱,尿酸分泌过多或肾脏排泄功能障碍,使尿酸在血液中积聚的状态。为规范临床一线医师高尿酸血症和痛风病证结合诊疗,中国医师协会中西医结合医师分会内分泌与代谢病学专业委员会组织制, cover=https://img.medsci.cn/2021310/1615389204263_2020535.jpg, journalId=0, articlesId=null, associationId=990, associationName=中国医师协会中西医结合医师分会, associationIntro=中国医师协会中西医结合医师分会(Doctor Society of integrative Medicine,Chinese Medical Doctor Association,DSIM/CMDA,以下简称分会)是由中华人民共和国卫生部主管,中华人民共和国民政部批准注册,隶属中国医师协会的二级学会组织,于2007年11月9日至10日在北京正式成立。享誉国内外的著名中西医结合专家陈可冀院士担任会长,以中国中医科学院西苑医院为依托单位,由来自全国26省市地区及香港特别行政区的代表共128人组成了第一届委员会,充分体现了广泛的学术和区域代表性。由具备长期从事中西医结合工作经历的执业医师、管理人员及团体组成的全国性、行业性、非盈利性的群众组织,分会本着中国医师协会&ldquo;服务、协调、自律、维权、监督、管理&rdquo;宗旨,致力于加强中西医结合医师队伍的建设和管理,弘扬以人为本、救死扶伤的人道主义,维护我国中西医结合医师的正当义务权益,发挥中西医结合的特色与互补优势,促进中西医学术交流,提高临床综合服务能力,弘杨传统中医药学术的继承和发展,为我国人民健康和社会主义建设服务。, copyright=0, guiderPublishedTime=Wed Jan 20 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>高尿酸血症是指机体嘌呤代谢紊乱,尿酸分泌过多或肾脏排泄功能障碍,使尿酸在血液中积聚的状态。为规范临床一线医师高尿酸血症和痛风病证结合诊疗,中国医师协会中西医结合医师分会内分泌与代谢病学专业委员会组织制定本指南。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=1530, tagName=痛风), TagDto(tagId=4057, tagName=高尿酸血症)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=4057, guiderKeyword=高尿酸血症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=18481, appHits=1315, showAppHits=0, pcHits=1741, showPcHits=17163, likes=7, shares=149, comments=64, approvalStatus=1, publishedTime=Thu Mar 11 00:10:14 CST 2021, publishedTimeString=2021-01-20, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=qiushida2, createdTime=Wed Mar 10 23:13:37 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Fri Jan 05 07:33:08 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=高尿酸血症和痛风病证结合诊疗指南_2021_01_20_.pdf)])
高尿酸血症和痛风病证结合诊疗指南_2021_01_20_.pdf
下载请点击:
评论区 (57)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2144304, encodeId=ac112144304e9, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac275680908, createdName=ms6000001049770252, createdTime=Thu Jun 22 23:45:24 CST 2023, time=2023-06-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1248166, encodeId=e3d8124816677, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1c8318108, createdName=ms1000001426972953, createdTime=Fri Sep 09 18:40:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213159, encodeId=79af121315946, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67df3725267, createdName=135434d0m28暂无昵称, createdTime=Thu Apr 21 15:04:39 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212652, encodeId=6abe1212652d2, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc292854358, createdName=qqnded, createdTime=Tue Apr 19 20:39:57 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205151, encodeId=9b19120515194, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a95451577, createdName=ZY-WS-LP, createdTime=Wed Mar 23 09:41:15 CST 2022, time=2022-03-23, status=1, ipAttribution=)]
    2023-06-22 ms6000001049770252 来自云南省

    感谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2144304, encodeId=ac112144304e9, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac275680908, createdName=ms6000001049770252, createdTime=Thu Jun 22 23:45:24 CST 2023, time=2023-06-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1248166, encodeId=e3d8124816677, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1c8318108, createdName=ms1000001426972953, createdTime=Fri Sep 09 18:40:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213159, encodeId=79af121315946, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67df3725267, createdName=135434d0m28暂无昵称, createdTime=Thu Apr 21 15:04:39 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212652, encodeId=6abe1212652d2, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc292854358, createdName=qqnded, createdTime=Tue Apr 19 20:39:57 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205151, encodeId=9b19120515194, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a95451577, createdName=ZY-WS-LP, createdTime=Wed Mar 23 09:41:15 CST 2022, time=2022-03-23, status=1, ipAttribution=)]
    2022-09-09 ms1000001426972953

    感谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2144304, encodeId=ac112144304e9, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac275680908, createdName=ms6000001049770252, createdTime=Thu Jun 22 23:45:24 CST 2023, time=2023-06-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1248166, encodeId=e3d8124816677, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1c8318108, createdName=ms1000001426972953, createdTime=Fri Sep 09 18:40:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213159, encodeId=79af121315946, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67df3725267, createdName=135434d0m28暂无昵称, createdTime=Thu Apr 21 15:04:39 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212652, encodeId=6abe1212652d2, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc292854358, createdName=qqnded, createdTime=Tue Apr 19 20:39:57 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205151, encodeId=9b19120515194, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a95451577, createdName=ZY-WS-LP, createdTime=Wed Mar 23 09:41:15 CST 2022, time=2022-03-23, status=1, ipAttribution=)]
    2022-04-21 135434d0m28暂无昵称

    谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2144304, encodeId=ac112144304e9, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac275680908, createdName=ms6000001049770252, createdTime=Thu Jun 22 23:45:24 CST 2023, time=2023-06-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1248166, encodeId=e3d8124816677, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1c8318108, createdName=ms1000001426972953, createdTime=Fri Sep 09 18:40:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213159, encodeId=79af121315946, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67df3725267, createdName=135434d0m28暂无昵称, createdTime=Thu Apr 21 15:04:39 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212652, encodeId=6abe1212652d2, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc292854358, createdName=qqnded, createdTime=Tue Apr 19 20:39:57 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205151, encodeId=9b19120515194, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a95451577, createdName=ZY-WS-LP, createdTime=Wed Mar 23 09:41:15 CST 2022, time=2022-03-23, status=1, ipAttribution=)]
    2022-04-19 qqnded

    感谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2144304, encodeId=ac112144304e9, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac275680908, createdName=ms6000001049770252, createdTime=Thu Jun 22 23:45:24 CST 2023, time=2023-06-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1248166, encodeId=e3d8124816677, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1c8318108, createdName=ms1000001426972953, createdTime=Fri Sep 09 18:40:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213159, encodeId=79af121315946, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67df3725267, createdName=135434d0m28暂无昵称, createdTime=Thu Apr 21 15:04:39 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212652, encodeId=6abe1212652d2, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc292854358, createdName=qqnded, createdTime=Tue Apr 19 20:39:57 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205151, encodeId=9b19120515194, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a95451577, createdName=ZY-WS-LP, createdTime=Wed Mar 23 09:41:15 CST 2022, time=2022-03-23, status=1, ipAttribution=)]
    2022-03-23 ZY-WS-LP

    学习

    0

拓展阅读

高尿酸血症和痛风治疗的中国专家共识

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2013-11-01

中国肾脏疾病高尿酸血症诊治的实践指南(2017版)

中国医师协会肾内科医师分会 · 2017-07-04

中国高尿酸血症相关疾病诊疗多学科专家共识

肾脏病相关专家小组(统称) · 2017-03-30

中国慢性肾脏病患者合并高尿酸血症诊治专家共识

中国慢性肾脏病患者合并高尿酸血症诊治共识专家组 · 2017-06-30

中国高尿酸血症与相关疾病诊疗多学科专家共识(英文版)

肾脏病相关专家小组(统称) · 2017-10-20

2018 台湾多学科共识:痛风及高尿酸血症的管理

台湾多学科工作组(统称) · 2018-01-24